{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:28:28Z","timestamp":1769621308743,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10815-025-03724-x","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:13:52Z","timestamp":1763018032000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Follicle Size at Trigger on Reproductive Outcomes in Letrozole-Modified Natural Frozen Embryo Transfer Cycles in High Responder Patients"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-5978","authenticated-orcid":false,"given":"Emre","family":"Pabuccu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugras","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"Pabuccu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"12","key":"3724_CR1","first-page":"2808","volume":"35","author":"S Santos-Ribeiro","year":"2020","unstructured":"Santos-Ribeiro S, Mackens S, Popovic Todorovic B, Racca A, Polyzos NP, VanLanduyt L, et al. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial. HumReprod. 2020;35(12):2808\u201318.","journal-title":"HumReprod"},{"issue":"6","key":"3724_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003414.pub4","volume":"6","author":"T Ghobara","year":"2025","unstructured":"Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for endometrial preparation prior to frozen embryo transfer. Cochrane Database Syst Rev. 2025;6(6):CD003414. https:\/\/doi.org\/10.1002\/14651858.CD003414.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"3724_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/humupd\/dmad011","volume":"5","author":"TR Zaat","year":"2023","unstructured":"Zaat TR, Kostova EB, Korsen P, Showell MG, Mol F, van Wely M. Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis. Hum Reprod Update. 2023;5(5):634\u201354. https:\/\/doi.org\/10.1093\/humupd\/dmad011.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"3724_CR4","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s10815-023-02956-z","volume":"40","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Fu X, Gao S, Gao S, Gao S, Ma J, et al. Letrozole use in vitrified single-blastocyst transfer cycles is associated with a lower risk of large-for-gestational-age infants in patients with polycystic ovary syndrome. J Assist Reprod Genet. 2023;40(12):2885\u201394. https:\/\/doi.org\/10.1007\/s10815-023-02956-z.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3724_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/humupd\/dmz029","volume":"25","author":"R Wang","year":"2019","unstructured":"Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019;25(6):717\u201332. https:\/\/doi.org\/10.1093\/humupd\/dmz029.","journal-title":"Hum Reprod Update"},{"issue":"14","key":"3724_CR6","doi-asserted-by":"publisher","first-page":"1250847","DOI":"10.3389\/fendo.2023.1250847.PMID:37711892;PMCID:PMC10497870","volume":"29","author":"YW Hsueh","year":"2023","unstructured":"Hsueh YW, Huang CC, Hung SW, Chang CW, Hsu HC, Yang TC, et al. Finding the optimal preparation and timing of the endometrium in frozen-thawed embryo transfer: a literature review of clinical evidence. Front Endocrinol (Lausanne). 2023Aug;29(14):1250847. https:\/\/doi.org\/10.3389\/fendo.2023.1250847.PMID:37711892;PMCID:PMC10497870.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3724_CR7","first-page":"378","volume-title":"Towards reproductive certianty: fertility and genetics beyond 1999","author":"D Gardner","year":"1999","unstructured":"Gardner D, Schoolcraft W. In vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Towards reproductive certianty: fertility and genetics beyond 1999. United Kingdom: Parthenon Publishing; 1999. p. 378\u201388."},{"key":"3724_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaf011","author":"NS B\u00fclow","year":"2025","unstructured":"B\u00fclow NS, Wissing ML, Macklon N, Pinborg A, L\u00f8ssl K. Reproductive outcomes after letrozole stimulated versus artificial frozen-thawed embryo transfer cycles in women with PCOS and\/or oligo-anovulation: a systematic review and meta-analysis. Hum Reprod Update. 2025. https:\/\/doi.org\/10.1093\/humupd\/dmaf011.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"3724_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajog.2021.08.018","volume":"226","author":"KP Conrad","year":"2022","unstructured":"Conrad KP, von Versen- H\u00f6ynck F, Baker VL. Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol. 2022;226(5):683\u201399. https:\/\/doi.org\/10.1016\/j.ajog.2021.08.018.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"3724_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/humrep\/deaa026","volume":"35","author":"S Mackens","year":"2020","unstructured":"Mackens S, Stubbe A, Santos- Ribeiro S, Van Landuyt L, Racca A, Roelens C, et al. To trigger or not to trigger ovulation in a natural cycle for frozen embryo transfer: a randomized controlled trial. Hum Reprod. 2020;35(5):1073\u201381. https:\/\/doi.org\/10.1093\/humrep\/deaa026.","journal-title":"Hum Reprod"},{"key":"3724_CR11","doi-asserted-by":"publisher","unstructured":"Alonso-Mayo C, Kohls G, Santos-Ribeiro S, Soares SR, Garcia-Velasco JA. The modified natural cycle allows a window of 7 days for frozen embryo transfer planning. Reprod Biomed Online. 2024 Jul;49(1):103774. https:\/\/doi.org\/10.1016\/j.rbmo.2023.103774. Epub 2023 Dec 17. PMID: 38609793.","DOI":"10.1016\/j.rbmo.2023.103774"},{"issue":"1","key":"3724_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.xfre.2024.12.001.PMID:40201096;PMCID:PMC11973811","volume":"6","author":"SK Kavoussi","year":"2024","unstructured":"Kavoussi SK, Chen SH, Farzaneh N, Farahi A, Mehrabani-Farsi R, Aston KI, et al. Impact of follicle size before luteal progesterone supplementation on clinical outcomes of modified natural cycle single frozen embryo transfer. F S Rep. 2024Dec 15;6(1):47\u201351. https:\/\/doi.org\/10.1016\/j.xfre.2024.12.001.PMID:40201096;PMCID:PMC11973811.","journal-title":"F S Rep"},{"issue":"4","key":"3724_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.fertnstert.2021.12.025","volume":"117","author":"N Mahutte","year":"2022","unstructured":"Mahutte N, Hartman M, Meng L, Lanes A, Luo ZC, Liu KE. Optimal EMT in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers. Fertil Steril. 2022Apr;117(4):792\u2013800. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.12.025. (Epub 2022 Jan 31 PMID: 35109980).","journal-title":"Fertil Steril"},{"key":"3724_CR14","doi-asserted-by":"publisher","unstructured":"Palatnik A, Strawn E, Szabo A, Robb P. What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles was performed . Fertil Steril. 2012 May;97(5):1089\u201394.e1\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.02.018. Epub 2012 Mar 28. PMID: 22459633.","DOI":"10.1016\/j.fertnstert.2012.02.018"},{"key":"3724_CR15","doi-asserted-by":"publisher","unstructured":"Cameron K, Abu- Rafea B, Vilos A, Hollett-Caines J, Rebel M, Van Oirschot M, et al. Optimal follicle size for human chorionic gonadotropin trigger in mono-follicular growth during letrozole-induced intrauterine insemination cycles: findings from a large retrospective study. Fertil Steril. 2025(2). https:\/\/doi.org\/10.1016\/j.fertnstert.2025.03.010.","DOI":"10.1016\/j.fertnstert.2025.03.010"},{"issue":"1","key":"3724_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.103862","volume":"49","author":"M Saupstad","year":"2024","unstructured":"Saupstad M, Bergenheim SJ, Bogstad JW, Petersen MR, Klajnbard A, Pr\u00e6torius L, et al. Progesterone concentrations on blastocyst transfer day in modified natural cycle frozen embryo transfer cycles. Reprod Biomed Online. 2024;49(1):103862. https:\/\/doi.org\/10.1016\/j.rbmo.2024.103862.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"3724_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/humupd\/dmab011","volume":"27","author":"Y Mizrachi","year":"2021","unstructured":"Mizrachi Y, Horowitz E, Ganer Herman H, Farhi J, Raziel A, Weissman A. Should women receive luteal support following natural cycle frozen embryo transfer? A systematic review and meta-analysis. Hum Reprod Update. 2021;27(4):643\u201350. https:\/\/doi.org\/10.1093\/humupd\/dmab011.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"3724_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.36157","volume":"7","author":"AJ Boxem","year":"2024","unstructured":"Boxem AJ, Blaauwendraad SM, Mulders AGMGJ, Bekkers EL, Kruithof CJ, Steegers EAP, et al. Preconception and early-pregnancy body mass index in women and men, time to pregnancy, and risk of miscarriage. JAMA Netw Open. 2024;7(9):e 2436157. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.36157.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"3724_CR19","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/humrep\/deaa092","volume":"1","author":"S Gaggiotti-Marre","year":"2020","unstructured":"Gaggiotti-Marre S, \u00c1lvarez M, Gonz\u00e1lez-Foruria I, Parriego M, Garcia S, Mart\u00ednez F, et al. Low progesterone levels on the day before natural cycle frozen embryo transfer are negatively associated with live birth rates. Hum Reprod. 2020;1(7):1623\u20139. https:\/\/doi.org\/10.1093\/humrep\/deaa092.","journal-title":"Hum Reprod"},{"issue":"6","key":"3724_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.rbmo.2022.06.027","volume":"45","author":"E Pabuccu","year":"2022","unstructured":"Pabuccu E, Kovanci E, Israfilova G, Tulek F, Demirel C, Pabuccu R. Oral, vaginal, or intramuscular progesterone in programmed frozen embryo transfer cycles: a pilot randomized controlled trial. Reprod Biomed Online. 2022;45(6):1145\u201351. https:\/\/doi.org\/10.1016\/j.rbmo.2022.06.027.","journal-title":"Reprod Biomed Online"},{"issue":"Issue Supplemen","key":"3724_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae108.238","volume":"39","author":"C Roelens","year":"2024","unstructured":"Roelens C, Mackens S, Van Landuyt L, De Vos M, Tournaye H, Blockeel C. Dydrogesterone versus micronized vaginal progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer cycles (REMODEL): an exploratory randomized controlled trial. Hum Reprod. 2024;39(Issue Supplement_1):deae108.238. https:\/\/doi.org\/10.1093\/humrep\/deae108.238.","journal-title":"Hum Reprod"},{"issue":"2","key":"3724_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/humrep\/dead256","volume":"39","author":"S Loreti","year":"2024","unstructured":"Loreti S, Thiele K, De Brucker M, Olsen C, Centelles-Lodeiro J, Bourgain C, et al. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium. Hum Reprod. 2024;39(2):403\u201312. https:\/\/doi.org\/10.1093\/humrep\/dead256.","journal-title":"Hum Reprod"},{"issue":"4","key":"3724_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10815-024-03049-1","volume":"41","author":"B Lawrenz","year":"2024","unstructured":"Lawrenz B, Kalafat E, Ata B, Del Gallego R, Melado L, Elkhatib I, et al. The combination of dydrogesterone and micronized vaginal progesterone can render serum progesterone level measurements on the day of embryo transfer and rescue attempts unnecessary in an HRT FET cycle. J Assist Reprod Genet. 2024;41(4):885\u201392. https:\/\/doi.org\/10.1007\/s10815-024-03049-1.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3724_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.rbmo.2023.02.007","volume":"46","author":"S Mackens","year":"2023","unstructured":"Mackens S, Pais F, Drakopoulos P, Amghizar S, Roelens C, Van Landuyt L, et al. Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial? Reprod Biomed Online. 2023;46(6):939\u201345. https:\/\/doi.org\/10.1016\/j.rbmo.2023.02.007.","journal-title":"Reprod Biomed Online"},{"key":"3724_CR25","unstructured":"Henry A, Santulli P, Bourdon M, Maignien C, Chapron C, Treluyer JM, Guibourdenche J, Chouchana L. Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). Hum Reprod Open. 2025 Jan 2;2025(1 ):hoae 072. 10.1093\/ hropen \/hoae072. Erratum in: Hum Reprod Open. 2025 Jun 03;2025(2 ):hoaf 029. 10.1093\/ hropen \/hoaf029. PMID: 39807112; PMCID: PMC11726828."},{"key":"3724_CR26","doi-asserted-by":"crossref","unstructured":"Pabuccu E, Aguilar A, de Azevedo Antunes R, Gefen E, Shulman LP. Why do the latest pharmacovigilance data not reflect the clinical experience with dydrogesterone? Hum Reprod Open 2025;2025:hoaf030. [DOI] [PMC free article] [PubMed] [Google Scholar].","DOI":"10.1093\/hropen\/hoaf030"},{"issue":"4","key":"3724_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.104789","volume":"50","author":"C Roelens","year":"2025","unstructured":"Roelens C, Blockeel C. Cycle management in frozen embryo transfer: the best of all worlds? Reprod Biomed Online. 2025;50(4):104789. https:\/\/doi.org\/10.1016\/j.rbmo.2024.104789.","journal-title":"Reprod Biomed Online"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03724-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:15:22Z","timestamp":1769249722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03724-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3724"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03724-x","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Ufuk University School of Medicine (reference no. 12024861\u201337).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work, the authors used ChatGPT 4o for language checks. After using this tool, the authors reviewed and edited the content and took full responsibility for the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI use"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}